BNET Industries
Last Fiscal Year Sales:$750.0K
- Private
- US
Number of Employees 2
Peer Companies
NAICS Code Custom Computer Programming Services: 541511
News & Analysis
Filter by
collaboration and network computer inc. - All News and Analysis
Arrowhead's New Nanobioscience Subsidiary Plans Preclinical Studies and Collaboration with NCI
- 2007-06-25
PASADENA, Calif. -- Arrowhead Research Corporation (NASDAQ:ARWR) announced today that its new wholly-owned nanobioscience subsidiary has changed its name from "C Sixty Acquisition Corp." to "Tego BioSciences Corporation." The subsidiary recently acquired the assets of C Sixty, Inc. and is focused on the development of new protective products based on...
Arcturus Veritas(R) Microgenomics Platform Selected for New NCI Funded Cancer Program in Collaboration With Children's Memorial Research Center
- 2005-03-14
The Division of Cancer Biology, NCI, announces the establishment of a program designed to train established and new NCI-funded investigators (or nominated post-doctoral fellows in their laboratories) in establishing, maintaining, manipulating and characterizing a variety of organotypic and orthotopic models of human cancer. The hands-on training program will be...
Xechem International Announced Today That it was Awarded $97,918 From the National Cancer Institute -NCI-, National Institutes of Health -NIH- for Their SBIR Proposal
- 2000-01-11
Business Editors NEW BRUNSWICK, N.J.--BUSINESS WIRE--Jan. 11, 2000 Xechem International, Inc. announced today that it was awarded $97,918 from the National Cancer Institute NCI, National Institutes of Health NIH for their Small Business Innovation Research SBIR proposal to investigate "BIOACTIVE NATURAL PRODUCTS FROM MARINE...
Lorus Therapeutics Broadens Collaboration with the U.S. National Cancer Institute; U.S. NCI to Test Novel Compounds for In Vivo Anti-Cancer Efficacy in Animal Models
- 1999-03-08
TORONTO--BUSINESS WIRE--March 8, 1999--Lorus Therapeutics (TSE:LOR.) (ME:LOR.) (Nasdaq:LORFF) Lorus Therapeutics Inc, on behalf of its 80 percent-owned subsidiary NuChem Pharmaceuticals Inc., today announced independent confirmation by the U.S. National Cancer Institute ("NCI") of the in vitro anti-cancer activity of its novel compounds currently under development.
NCI Advances Collaboration On Angiogenesis Inhibitors.
- 1998-06-08
THE NATIONAL CANCER Institute NCI is collaborating with EntreMed Inc., a Rockville, Md.-based biopharmaceutical company, and Bristol Myers Squibb on the production of two angiogenesis inhibitors, endostatin and angiostatin, respectively. The pr THE NATIONAL CANCER Institute NCI is collaborating with EntreMed ...
- 1
White Papers, Webcasts, and Resources
- IT Consolidation with VMware and Dell Equallogic iSCSI SANs a Fully Virtualized IT Environment - Simple to Deploy, Manage and Grow Dell EqualLogic Organizations trying to achieve higher levels of efficiency in their data ... Download Now
- Resource Guide: 10 Tech Skills You Should Develop Over the Next Five Years TechRepublic If you want a job where you can train in a particular skill set and then ... Download Now
- Storage Choices For Virtual Server Environments Dell EqualLogic Server virtualization is the most substantial shift in IT so far this ... Download Now
Industry Transcripts by Seeking Alpha
-
NaviSite, Inc. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 10, 2009about NAVI
-
Methode Electronics Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about MEI
-
Asure Software F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 10, 2009about ASUR
-
Ciena Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 10, 2009about CIEN
-
Streamline Health Solutions, Inc. Q3 2009 Earnings Call Transcript
on Dec 09, 2009about STRM
Glass Door
Technology Industry Companies
| Company | Employer Rating |
 |
|
| Microsoft | |
| Cisco Systems | |
| QUALCOMM | |
IndustryTop Rated
Presented by American Express